FANCM and breast cancer: While in non-Finnish Europeans these are the three most common FANCM truncating variants, their carrier frequency is low being 0.033, 0.21 and 0.21%, respectively (https://gnomad.broadinstitute.org/).15 We conducted large case-control studies in 67,112 unselected breast cancer cases, 53,766 controls, and 26,662 carriers of BRCA1 or BRCA2 pathogenic variants.